David Chu is an Ophthalmologist in Palisades Park, New Jersey. Dr. Chu is highly rated in 24 conditions, according to our data. His top areas of expertise are Uveitis, Scleritis, Interstitial Keratitis, Corneal Transplant, and Cataract Removal.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is highly rated in 15 conditions, according to our data. His top areas of expertise are Retinoblastoma, Retinitis Pigmentosa, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.

Kim Landzberg is an Ophthalmologist in Riverdale, New York. Dr. Landzberg is highly rated in 12 conditions, according to our data. Her top areas of expertise are Glaucoma, Cataract, Allergic Conjunctivitis, and Conjunctivitis (Pink Eye).

John Kim is an Ophthalmologist in New York, New York. Dr. Kim is highly rated in 6 conditions, according to our data. His top areas of expertise are Dry Eye Syndrome, Glaucoma, Ocular Hypertension (OHT), and Cataract.

Dr. George A. (Jack) Cioffi is an internationally recognized glaucoma scientist and clinician and is the Edward S. Harkness Professor and Chair of the Department of Ophthalmology at Columbia University Vagelos College of Physicians and Surgeons since 2012. He also holds the Jean and Richard Deems Endowed Professorship and is the Ophthalmologist-in-Chief at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center. From 2014 to 2023, Dr. Cioffi served as the President of ColumbiaDoctors, the multi-specialty faculty practice organization of more than 2,500 clinicians from Columbia University Irving Medical Center and was concurrently appointed Vice Dean of Clinical Affairs. Dr. Cioffi formerly held the Richard G. Chenoweth Chair of Ophthalmology at the Devers Eye Institute and was the Chief Medical Officer & Senior Vice President at Legacy Health System in Portland, Oregon. He received his medical degree at the University of South Carolina, completed a residency in ophthalmology at the University of Maryland where he also served as Chief Resident, and a fellowship in Research & Clinical Glaucoma at Devers Eye Institute under Dr. E. Michael Van Buskirk. Subsequently, he completed the inaugural Harvard Business School program in Managing Healthcare Delivery.Dr. Cioffi is the Editor-in-Chief of Journal of Academic Ophthalmology, the official journal of the Association of University Professors of Ophthalmology (AUPO). As well, he is Editor Emeritus of the Journal of Glaucoma, after serving for 10 years as the Editor-in-Chief, and he is the past Chair of the Basic and Clinical Science Course for the American Academy of Ophthalmology. He is the Chair of the Scientific Advisory Committee for the Glaucoma Research Foundation in San Francisco. He is a past President of the Oregon Academy of Ophthalmology and has served as a member of the FDA Ophthalmology/Dermatology Advisory Committee for drug approval. He also served on the Board of Directors for the Foundation for Medical Excellence and was selected by the Governor John Kitzhaber to serve on the Oregon Health Policy Board’s Outcomes & Quality taskforce. Dr. Cioffi, a physician for more than 30 years, has published over 250 articles, has enjoyed support from the National Eye Institute of the National Institutes of Health for more than two decades. He has delivered numerous named lectures and has received the Honor Award, the Senior Honor Award and two Secretariat Awards from the AAO. He has mentored more than 50 clinical and post-doctoral fellows over his career. These clinicians and scientists are now at academic institutions and in practices around the U.S., Canada, Europe, Asia, and Australia. Dr. Cioffi is highly rated in 5 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal.

Dr. C. Gustavo De Moraes is an Associate Professor of Clinical Ophthalmology at the Columbia University Medical Center and Attending Physician at New York Presbyterian Hospital. He sees patients with or at risk of developing glaucoma. Dr. De Moraes completed a glaucoma fellowship at the New York Eye and Ear Infirmary (NYEEI), later directing the Glaucoma Research Unit at the Einhorn Clinical Research Center of the NYEEI. He was also a Research Associate Professor of Ophthalmology at New York University (NYU).Dr. De Moraes is a member of the American Medical Association (AMA), American College of Surgeons (ACS), American Academy of Ophthalmology (AAO), Association for Research in Vision and Ophthalmology (ARVO), American Glaucoma Society (AGS), New York Glaucoma Society (NYGS), Ophthalmic Laser and Imaging Society (OLIS). He is past chair of the Associate Advisory Board of the World Glaucoma Association (WGA), and Education Committee of the International Council of Ophthalmology (ICO). Dr. De Moraes is the current Associate Editor for the journal Investigative Ophthalmology and Vision Sciences (IOVS), and co-chair of Glaucoma Progression Scholas (GPS). Dr. De Moraes has twice received the American Academy of Ophthalmology (AAO) Achievement Award. His clinical research has been funded by the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Research to Prevent Blindness (RPB). Dr. De Moraes is highly rated in 4 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Vitrectomy.

Michael Kazim is an Ophthalmologist in New York, New York. Dr. Kazim is highly rated in 13 conditions, according to our data. His top areas of expertise are Thyroid Eye Disease, Graves Disease, Optic Glioma, Turbinectomy, and Endoscopy.

Armand Fasano is an Ophthalmologist in West New York, New Jersey. Dr. Fasano is highly rated in 13 conditions, according to our data. His top areas of expertise are Optic Atrophy Type 1, Optic Nerve Atrophy, Neurotrophic Keratitis, and Cataract.

Alan Uliss is an Ophthalmologist in Bronx, New York. Dr. Uliss is highly rated in 10 conditions, according to our data. His top areas of expertise are Retinal Vasculopathy with Cerebral Leukodystrophy, Familial Exudative Vitreoretinopathy, Coats Disease, and Kallikrein Hypertension.

Louis Pasquale is an Ophthalmologist in New York, New York. Dr. Pasquale is highly rated in 10 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Hormone Replacement Therapy (HRT).

Quan Hoang is an Ophthalmologist in New York, New York. Dr. Hoang is highly rated in 9 conditions, according to our data. His top areas of expertise are Nearsightedness, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Irmak Karaca is an Ophthalmologist in New York, New York. Dr. Karaca has been practicing medicine for over 13 years is highly rated in 8 conditions, according to our data. Her top areas of expertise are Uveitis, Episcleritis, Scleritis, Vitrectomy, and Cataract Removal.

Nisha Chadha is an Ophthalmologist in New York, New York. Dr. Chadha is highly rated in 7 conditions, according to our data. Her top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Cataract Removal.

Christopher Brown is an Ophthalmologist in Teaneck, New Jersey. Dr. Brown is highly rated in 6 conditions, according to our data. His top areas of expertise are Cataract, Dry Eye Syndrome, Glaucoma, and Blepharitis.

Peter Hersh is an Ophthalmologist in Teaneck, New Jersey. Dr. Hersh has been practicing medicine for over 44 years is highly rated in 2 conditions, according to our data. Her top areas of expertise are Keratoconus, Astigmatism, Pterygium, Fuchs Dystrophy, and Corneal Transplant.

Steven Greenstein is an Ophthalmologist in Teaneck, New Jersey. Dr. Greenstein is highly rated in 2 conditions, according to our data. His top areas of expertise are Keratoconus, Astigmatism, Blepharitis, Interstitial Keratitis, and Corneal Transplant.

Marta Contreras is an Ophthalmologist in Hackensack, New Jersey. Dr. Contreras is highly rated in 2 conditions, according to our data. Her top areas of expertise are Retinopathy of Prematurity, Chalazion, Eyelid Bump, and Meibomianitis.

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is highly rated in 25 conditions, according to our data. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Philip Ferrone is an Ophthalmologist in Elmhurst, New York. Dr. Ferrone is highly rated in 23 conditions, according to our data. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Coats Disease, and Vitrectomy.

Dr. Spaide specializes in diseases of the retina and vitreous. His particular interests include retinal surgery, Macular Degeneration, Macular Holes, Macular Pucker, Diabetic Retinopathy, and intraocular inflammation. He has published more than 300 articles and 50 book chapters and 9 books about the diagnosis and treatment of Retinal Diseases. He has given lectures around the world.He has a remarkable number of “firsts” in retinal diseases including the development of autofluorescence imaging using a fundus camera and the first practical method to image deeper structures in the eye with optical coherence tomography. These imaging methods now are used around the world. He has described many new findings and diseases of the eye and helped develop many novel treatments. He has developed numerous surgical instruments that were named after him and holds patents for ophthalmic inventions.He is the recipient of the Richard and Hilda Rosenthal Foundation Award in the Visual Sciences, the Senior Honor Award from the American Society of Retinal Surgeons, and the Senior Achievement Award from the American Academy of Opthalmology and the Prix Soubrane de la Recherche en Ophthalmologie, Award of Merit from the Retina Society, the Henkind Award, Coscas Award, Nataraja Pillai Award, W. Richard Green MD Award, George Theodossiadis Award, Founders Award, American Society of Retinal Surgeons, Life Achievement Honor Award, and the American Academy of Ophthalmology. Dr. Spaide is highly rated in 16 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, Geographic Atrophy, and Vitrectomy.

"Stephen H. Tsang, M.D, Ph.D. is an acclaimed clinical geneticist in the care of individuals with retinal degenerations. He has been culturing stem cells since 1992 and created the first mouse model for a recessive form of retinitis pigmentosa (RP) by applying genome engineering to stem cell technology in 1995. He successfully treated preclinical models of Pde6a, Pde6b, Mfrp, Rho, Cngb1 and autosomal recessive bestrophin retinopathies.He has expertise in designing and testing genome engineering strategies in pre-clinical models, developing patient-specific knock-in models, generating of patient cell lines and providing care to patients with a precision medicine approach. He is also leading efforts in FDA trials for gene therapies, including PDE6A, RAB geranylgeranyl transferase, RPGR, CNGB3, CNGA3 and ABCA4 retinopathies. He wrote 3 books: “Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics"" and “Stem Cell Biology and Regenerative Medicine in Ophthalmology”, Springer Press, NY; and “CRISPR Genome Surgery in Stem Cells and Disease Tissues”, Elsevier Inc. He is an elected member of several honorary societies including the American Society for Clinical Investigation, Alcon Research Institute and American Ophthalmological Society. He is consistently named to various NIH study sections (DPVS standing member 2014-8 and PED2 2022-6) and other review committees; Alcon Research Institute Grant Review Committee (2022-27), Scientific Advisory Panel - Research to Prevent Blindness (RPB, 2019-29), Chair of American Ophthalmological Society Thesis Review Committee (2022-2023). Many of his publications are in widely-read general interest journals such as Science, NEJM, Lancet, Cell Stem Cell, Nature Genetics, and Journal of Clinical Investigation, which attests to the broad impact that his work has had.Dr. Tsang received a resident teaching award in 2008 and was the Columbia Ophthalmology Basic Science Course Director (2006-2018). Dr. Tsang graduated from Johns Hopkins University, where he began his medical genetics training under the tutelage of Professor Victor A. McKusick. He received his M.D. and Ph.D. degrees from the NIH-National Institute of General Medical Sciences Medical Scientist Training Program (MSTP) at Columbia University. Dr. Tsang then completed his residency at Jules Stein Eye Institute/UCLA, followed by studies with Professors Alan C. Bird and Graham E. Holder on improving the care of individuals with macular degenerations.". Dr. Tsang is highly rated in 14 conditions, according to our data. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Sorsby Fundus Dystrophy, Leber Congenital Amaurosis, and Usher Syndrome.

Dr. Jason Horowitz, Professor of Ophthalmology at Columbia University Irving Medical Center, joined Columbia in 2011 after a rewarding 25-year experience delivering retinal care to the Waterbury, Connecticut community. A graduate of Harvard College and Yale Medical School, Dr. Horowitz was an ophthalmology resident at Yale before completing a retinal fellowship at Cornell, where he trained under Dr. Stanley Chang.Dr. Horowitz’s interests in ophthalmology are wide ranging. He is currently Medical Director of the Residents’ Eye Clinic at Harkness, where some of the most complicated and diverse patients in the world are evaluated and treated for an astonishing variety of ocular diseases. In a completely different domain, Dr. Horowitz has assumed the role of performing essential evaluations for retinopathy of prematurity in the infant patients of the world famous neonatal intensive care unit at Columbia’s Morgan Stanley Children’s Hospital of New York.In yet another realm, Dr. Horowitz manages complex retinal and macular disorders in adults such as retinal detachments and macular pucker. Together with his 36 years of retinal practice experience, Dr. Horowitz employs the full range of cutting-edge medical and surgical modalities in his practice. He particularly values the ability to use the most improved, up-to-date laser, pharmacological, and surgical therapies to successfully prevent (and, in some cases, even correct) profound visual impairment in conditions such as diabetic retinopathy and macular holes or epiretinal membranes. Dr. Horowitz is highly rated in 10 conditions, according to our data. His top areas of expertise are Retinopathy of Prematurity, Retinal Detachment, Glaucoma, Vitrectomy, and Iridectomy.

Steven Odrich is an Ophthalmologist in Riverdale, New York. Dr. Odrich is highly rated in 10 conditions, according to our data. His top areas of expertise are Cataract, Glaucoma, Meibomianitis, Dry Eye Syndrome, and Vitrectomy.

Dr. Paul T. Finger has collected or discovered the latest and most advanced medical technologies for the diagnosis and treatment of ocular tumors and eye cancer.With great respect for collaboration, he works closely with you, your referring doctor and his associated specialists to provide the most excellent care possible.The New York Eye Cancer Center was designed to be a responsive and caring environment, we strive to be your and your doctor's first choice for eye cancer care.Dr. Finger is the Director of Ocular Tumor Services at the Manhattan Eye, Ear and Throat Hospital and teaches residents from the New York University School of Medicine.A world-recognized expert in radiation and surgical techniques to conserve the eye and vision; Dr. Finger has pioneered the use of palladium-103 plaque radiation for choroidal melanoma, 3D and high-frequency ultrasound to image intraocular tumors, and created this world-renowned web site. Dr. Finger publishes in the major clinical journals and lectures frequently at local, national and international meetings. He graduated from Tulane Medical School, the Manhattan Eye, Ear and Throat Hospital, and then completed specialty training in treatment of ocular tumors and orbital diseases.Dr. Finger is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology and sees patients from all over the world.Dr Finger was a principal investigator for The Collaborative Ocular Melanoma Study. He Chaired the Ophthalmic Oncology Task Force that wrote the 2014 consensus guidelines for plaque radiationt therapy of choroidal melanoma and retinoblastoma for The American Brachytherapy Society. Dr. Finger was the clinical director for the Plaque Radiation Therapy (Task Group 129) of the American Association for Physicists in Medicine (AAPM). Dr. Finger is Chair of the Ophthalmic Oncology Task Group of The American Joint Committee on Cancer (AJCC) - International Union Against Cancer (UICC). The AJCC-UICC has created a universal language (TNM-classification) commonly used around the world to describe eye cancer.Dr. Finger has a particular interest in melanoma of the choroid, ciliary body and iris. He has written extensively about new ways to detect and treat retinoblastoma, conjunctival melanoma, squamous carcinoma, metastatic cancer to the eye and orbital tumors.Dr. Finger has assembled a team to care for patients with eye tumors. By picking the best doctors from several institutions, his team includes the top radiation, medical and pediatric oncologists from several institutions in New York City.Dr. Finger has spent his career inventing and improving new methods of diagnosis and treatment for eye cancer:. Dr. Finger is highly rated in 10 conditions, according to our data. His top areas of expertise are Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Iridectomy, and Vitrectomy.

Tongalp H. Tezel, MD is the Chang Family Endowed Professor of Ophthalmology and the Director of the Vitreoretinal Service and Fellowship Program at the Department of Ophthalmology. Dr. Tezel is an internationally known clinician-scientist and a leader in the management of vitreoretinal diseases. Dr. Tezel received his medical degree and initial ophthalmology training in Ankara, Turkey at Hacettepe University, School of Medicine, and completed his ophthalmology residency at Washington University School of Medicine. He later trained under Dr. Stanley Chang and received his fellowship in vitreoretinal surgery here at Columbia University.He is a fellow of the American Academy of Ophthalmology, American Society of Retina Specialists, the Macula Society, The Retina Society, and the Association for Research in Vision and Ophthalmology. He has received numerous honors, including the Fellow of the Association for Research in Vision and Ophthalmology (FARVO), American Academy of Ophthalmology's Achievement Award, Alpha Omega Alpha Faculty Membership; Honor Award of the American Society of Retina Specialist, and several Awards for Excellence in Teaching. He is listed on the Best Doctors of America and Castle Connolly's Top Doctor Directory.Dr. Tezel's research laboratory focuses on investigating the molecular mechanisms of various retinal diseases. His main research interests include gene therapy for age-related macular degeneration, inherited retinal diseases, retinal stem cell transplantation, angiogenesis, pharmacologic vitreolysis, and tissue engineering. He has developed several techniques used for tissue engineering and retinal cell replacement therapies, awarded numerous patents for his contributions. Recently, he has embarked on gene treatment and tissue engineering trials for macular degeneration.Dr. Tezel is an ad-hoc reviewer for several journals in his field and has been contributing to the development of the vitreoretinal field with several publications, presentations, and invited lectures. Dr. Tezel is highly rated in 9 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, Central Serous Chorioretinopathy, and Vitrectomy.